Key Details
Price
$15.27Annual ROE
-89.13%Beta
0.26Events Calendar
Next earnings date:
Mar 18, 2025Recent quarterly earnings:
Nov 14, 2024Recent annual earnings:
Mar 18, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Aug 28, 2024Analyst ratings
Recent major analysts updates
04 Dec '24 Chardan Capital
Buy15 Nov '24 Chardan Capital
Buy19 Aug '24 Chardan Capital
Buy30 May '24 Brookline Capital
Buy08 Apr '24 Ladenburg Thalmann
Buy20 Sept '21 Chardan Capital
Neutral03 Sept '21 Truist Securities
Hold03 Sept '21 Ladenburg Thalmann
Neutral03 Sept '21 Chardan Capital
Sell03 Sept '21 Brookline Capital
HoldMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Forte Biosciences doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Forte Biosciences (FBRX) Is a Great Choice for 'Trend' Investors, Here's Why
FBRX
zacks.com03 January 2025
Forte Biosciences (FBRX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Here's Why Momentum in Forte Biosciences (FBRX) Should Keep going
FBRX
zacks.com28 November 2024
Forte Biosciences (FBRX) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Forte Biosciences (FBRX) Upgraded to Buy: What Does It Mean for the Stock?
FBRX
zacks.com19 November 2024
Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
What Makes Forte Biosciences (FBRX) a New Buy Stock
FBRX
Zacks Investment Research25 March 2024
Forte Biosciences (FBRX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
FAQ
- What is the primary business of Forte Biosciences?
- What is the ticker symbol for Forte Biosciences?
- Does Forte Biosciences pay dividends?
- What sector is Forte Biosciences in?
- What industry is Forte Biosciences in?
- What country is Forte Biosciences based in?
- When did Forte Biosciences go public?
- Is Forte Biosciences in the S&P 500?
- Is Forte Biosciences in the NASDAQ 100?
- Is Forte Biosciences in the Dow Jones?
- When was Forte Biosciences's last earnings report?
- When does Forte Biosciences report earnings?
- Should I buy Forte Biosciences stock now?
What is the primary business of Forte Biosciences?
Forte Biosciences (FBRX) is a biotechnology company focused on developing innovative treatments for skin diseases. They aim to improve patients' lives by creating effective therapies, particularly for conditions like eczema and other inflammatory skin disorders. Their research combines science and technology to find new solutions.
What is the ticker symbol for Forte Biosciences?
The ticker symbol for Forte Biosciences is NASDAQ:FBRX
Does Forte Biosciences pay dividends?
No, Forte Biosciences does not pay dividends
What sector is Forte Biosciences in?
Forte Biosciences is in the Healthcare sector
What industry is Forte Biosciences in?
Forte Biosciences is in the Biotechnology industry
What country is Forte Biosciences based in?
Forte Biosciences is headquartered in United States
When did Forte Biosciences go public?
Forte Biosciences's initial public offering (IPO) was on 13 April 2017
Is Forte Biosciences in the S&P 500?
No, Forte Biosciences is not included in the S&P 500 index
Is Forte Biosciences in the NASDAQ 100?
No, Forte Biosciences is not included in the NASDAQ 100 index
Is Forte Biosciences in the Dow Jones?
No, Forte Biosciences is not included in the Dow Jones index
When was Forte Biosciences's last earnings report?
Forte Biosciences's most recent earnings report was on 14 November 2024
When does Forte Biosciences report earnings?
The next expected earnings date for Forte Biosciences is 18 March 2025
Should I buy Forte Biosciences stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions